Easy availability and being the doctors’ preferred prescription during the second wave.
The company has sold 350 crore tablets since the Covid-19 outbreak in 2020, and earned revenues of Rs 400 crore in a year
Dolo-650 gets recognized as India’s Leading Brand at the Indian Brand and Leadership Conclave 2022 organized by The Brand Story.
Today, Dolo-650 is the 6th largest brand (as per AWACS) in the Indian Pharmaceutical Market became the number one prescribed brand of paracetamol solid oral doses in India.
Micro Labs Ltd introduces Trisopt: World’s first triple drug fixed-dose combination for Glaucoma Management.Trisopt is an indigenous development from Micro Labs, manufactured in their state-of-the-art facility located in Sikkim.